ArticleFrontiers in genetics2022

Utilization of hypoxia-derived gene signatures to predict clinical outcomes and immune checkpoint blockade therapy responses in prostate cancer.

Minhua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.